Next Article in Journal
Genetic versus Non-Genetic Regulation of miR-103, miR-143 and miR-483-3p Expression in Adipose Tissue and Their Metabolic Implications—A Twin Study
Next Article in Special Issue
Applicability of Next Generation Sequencing Technology in Microsatellite Instability Testing
Previous Article in Journal
Imprinted Genes and the Environment: Links to the Toxic Metals Arsenic, Cadmium and Lead
Previous Article in Special Issue
Abnormal Base Excision Repair at Trinucleotide Repeats Associated with Diseases: A Tissue-Selective Mechanism
Article Menu

Export Article

Open AccessDiscussion
Genes 2014, 5(3), 497-507; doi:10.3390/genes5030497

Lynch Syndrome: An Updated Review

Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland
*
Author to whom correspondence should be addressed.
Received: 3 December 2013 / Revised: 30 April 2014 / Accepted: 9 May 2014 / Published: 27 June 2014
(This article belongs to the Special Issue Microsatellite Instability)
View Full-Text   |   Download PDF [100 KB, uploaded 27 June 2014]

Abstract

Lynch syndrome is one of the most common cancer susceptibility syndromes. Individuals with Lynch syndrome have a 50%–70% lifetime risk of colorectal cancer, 40%–60% risk of endometrial cancer, and increased risks of several other malignancies. It is caused by germline mutations in the DNA mismatch repair genes MLH1, MSH2, MSH6 or PMS2. In a subset of patients, Lynch syndrome is caused by 3' end deletions of the EPCAM gene, which can lead to epigenetic silencing of the closely linked MSH2. Relying solely on age and family history based criteria inaccurately identifies eligibility for Lynch syndrome screening or testing in 25%–70% of cases. There has been a steady increase in Lynch syndrome tumor screening programs since 2000 and institutions are rapidly adopting a universal screening approach to identify the patients that would benefit from genetic counseling and germline testing. These include microsatellite instability testing and/or immunohistochemical testing to identify tumor mismatch repair deficiencies. However, universal screening is not standard across institutions. Furthermore, variation exists regarding the optimum method for tracking and disclosing results. In this review, we summarize traditional screening criteria for Lynch syndrome, and discuss universal screening methods. International guidelines are necessary to standardize Lynch syndrome high-risk clinics. View Full-Text
Keywords: Lynch syndrome; genetics; screening; history; CRC clinic Lynch syndrome; genetics; screening; history; CRC clinic
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Sehgal, R.; Sheahan, K.; O'Connell, P.R.; Hanly, A.M.; Martin, S.T.; Winter, D.C. Lynch Syndrome: An Updated Review. Genes 2014, 5, 497-507.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top